BioNTech SE (BNTX) Current Deferred Tax Assets (2019 - 2022)
BioNTech SE's Current Deferred Tax Assets history spans 4 years, with the latest figure at $73.6 million for Q3 2022.
- On a quarterly basis, Current Deferred Tax Assets changed N/A to $73.6 million in Q3 2022 year-over-year; TTM through Sep 2022 was $73.6 million, a N/A change, with the full-year FY2021 number at $55.5 million, up 66.19% from a year prior.
- Current Deferred Tax Assets hit $73.6 million in Q3 2022 for BioNTech SE, down from $80.7 million in the prior quarter.
- Over the last five years, Current Deferred Tax Assets for BNTX hit a ceiling of $90.6 million in Q1 2022 and a floor of $6.5 million in Q4 2019.
- Historically, Current Deferred Tax Assets has averaged $54.0 million across 4 years, with a median of $55.5 million in 2021.
- Biggest five-year swings in Current Deferred Tax Assets: skyrocketed 414.51% in 2020 and later surged 66.19% in 2021.
- Tracing BNTX's Current Deferred Tax Assets over 4 years: stood at $6.5 million in 2019, then skyrocketed by 414.51% to $33.4 million in 2020, then surged by 66.19% to $55.5 million in 2021, then skyrocketed by 32.66% to $73.6 million in 2022.
- Business Quant data shows Current Deferred Tax Assets for BNTX at $73.6 million in Q3 2022, $80.7 million in Q2 2022, and $90.6 million in Q1 2022.